What we Provide ?

We provide PCD pharma franchise to individuals or teams who are willing to work for themselves.

Our Advantage

Variety of  products across different divisions like Gynae, Paediatric, Ortho, Cardiac-Diabetic, Derma & Ayurvedic etc.

Why Choose Us ?

Excellent customer service with attractive product packings at highly competitive rates.

Lanchestor Biotech MOBILE APP


Visual Aids, Product Pictures and Indications all at one place.

PTR & PTS CALCULATOR

About Lanchestor Biotech


Lanchestor Biotech a leading pcd pharmaceutical company in India. We are manufacturers and suppliers of finished pharmaceutical medicines since last 10 years all over India. We have a wide range of product portfolio consisting of tablets, capsules, injectable, syrups, ointments, eye, ear and nasal drops. Our products are manufactured at one of the best art of state manufacturing facilities, which are WHO and GMP certified units.

Read More

Query Form


Testimonials


Our Vision


Under the guidance of our MD Mr. Sachin Gulat, Lanchestor Biotech is continuously pacing forwards towards strengthening three pillars of our healthcare system:

  • Affordability
  • Accessibility
  • Availability

We are constantly trying to make the products more affordable by setting up our own manufacturing units as soon as possible.

We are also planning to open our dispatch centres in Central & East India in order to make products more accessible to our clients.

To ensure the availability of products in each and every part of India, we are constantly appointing new clients in order to cover as much ground as possible.

Product Efficacy 99.9%
Product Packing 95%
Product Availability 95%
Price Competitiveness 95%

What are the Requirements for taking PCD Pharma Franchise?

Click Here to Know

Address


Plot 455, Phase-1, Industrial Area

Panchkula, Haryana

Pin Code: 134113

Contact Us

Want Franchise for your Area ?


We at Lanchestor Biotech a would be happy to help you. Just put in your details below and we will take care of everything.